CHE · NYSE · STOCK
Chemed (CHE) Stock Analysis
$503.05
52W $365.21 – $557.00
62/100
$6.59B
25.3
0.51
Is CHE Bullish or Bearish?
Bullish.
Innellis AI committee rates Chemed Corp. (CHE) Buy with a composite score of 62/100
, based on 6 analysts with 50% agreement.
Last updated September 21, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +13.33 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -6.67 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull & Bear Case
Bull Case
- ROE of 29.4% shows genuine earnings power backing the valuation — Value
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
- Low leverage (debt-to-equity 0.01) -- balance sheet can absorb a shock — Risk
Bear Case
- Price-to-book of 6.2x prices in significant intangible value — Value
- RSI at 29 is in oversold territory (could mean either capitulation or a bounce setup) — Technical
- MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of September 21, 2026
Overall Committee Score
62/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 24%
of 192 Healthcare peers
Value Analyst
neutral
59
/ 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 29.4% shows genuine earnings power backing the valuation
− Price-to-book of 6.2x prices in significant intangible value
Growth Analyst
bullish
62
/ 100 · Moderate confidence
Strong, accelerating growth with consistent execution
+ Quarter-over-quarter growth rate is ACCELERATING, not just positive
Technical Analyst
neutral
46
/ 100 · High confidence
Mixed or range-bound price action
+ Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement
− RSI at 29 is in oversold territory (could mean either capitulation or a bounce setup)
Risk Analyst
bullish
80
/ 100 · Low confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
+ Low leverage (debt-to-equity 0.01) -- balance sheet can absorb a shock
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
neutral
58
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2518.64)
Investment Thesis Evolution
Committee score moved marginally from 61.7 to 61.7.
Comparing 2026-09-20 to 2026-09-21 (1 day apart).
Technical Analysis
RSI (14)
28.6
Oversold
MACD Histogram
-2.762
Bearish Momentum
Trend Direction
Sideways
Weekly: Sideways
Market Structure
Mixed
Support
$499.35
Resistance
$507.64
Bollinger %B
0.15
Inside Bands
Price vs Moving Averages
EMA 9
$510.94
Below
EMA 21
$517.59
Below
EMA 50
$511.45
Below
EMA 200
$473.77
Above
Fundamental Analysis
Valuation
20
Growth
68
Profitability
70
Financial Health
55
Cash Flow
70
Valuation
P/E Ratio
25.3×
P/B Ratio
8.15×
PEG Ratio
17.13
Dividend Yield
0.50%
52W High
$557.00
52W Low
$365.21
Quality & Growth
ROE
2708.1%
ROA
1617.3%
Gross Margin
3044.2%
Operating Margin
1345.6%
Revenue Growth YoY
—
Debt / Equity
0.40
AI Fundamental Assessment
P/E ratio of 25.3 (moderate relative to a 15-40x range); Price-to-book of 8.1x; PEG ratio of 17.1 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 27.1%; Return on assets of 16.2%; Net margin of 10.6%; Gross margin of 30.4%; Current ratio of 0.91 (tight short-term liquidity); Debt-to-equity of 0.40; Free cash flow per share is positive (24.11); Most recent quarter beat estimates by 7.1%; 2 consecutive earnings beats; EPS growth accelerating (-12.0% -> +7.3% QoQ); Average YoY EPS growth of 41.9%; Analyst estimates falling over recent quarters
Get the Full CHE Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →